Author:
Cahn Pedro,Cassetti Isabel,Wood Robin,Phanuphak Praphan,Shiveley LeeAnn,Bethell Richard C,Sawyer James
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Reference15 articles.
1. Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection;Wainberg;Antivir Ther,2005
2. The in vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for the treatment of HIV infection;Gu;Antimicrob Agents Chemother,2006
3. In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIs;Bethell;Antivir Chem Chemother,2005
4. Pharmacokinetics (PK) of SPD754, a new cytidine analogue, in healthy volunteers;Francis;Antiviral Ther,2003
5. Anti-human immunodeficiency virus type 1 activity, intracellular metabolism and pharmacokinetics evaluation of 2′-deoxy-3′-oxa-4′-thiocytidine;De Muys;Antimicrob Agents Chemother,1999
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献